have found that the combination of the CA IX/CD147 antibodies achieved higher efficiency in the NanoVelcro platform compared to EPCAM-based methods for capturing circulating cells coming from the renal carcinoma.89 The gene discussed is CA9; the disease is renal carcinoma.